Purchase this article with an account.
G Inana, Y Hotta, C Zintz, K Takki, R G Weleber, N G Kennaway, K Nakayasu, A Nakajima, T Shiono; Expression defect of ornithine aminotransferase gene in gyrate atrophy.. Invest. Ophthalmol. Vis. Sci. 1988;29(7):1001-1005.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
A generalized deficiency in the mitochondrial enzyme, ornithine aminotransferase (OAT: EC 22.214.171.124), is the hallmark of gyrate atrophy (GA), a hereditary degenerative disease of the choroid and retina of the eye that leads to blindness. A human OAT cDNA, previously constructed and characterized in our laboratory, and anti-human OAT antibody were used as probes to examine the OAT gene, mRNA and protein of GA patients. A blot analysis of the genomic DNAs, RNAs and proteins of 14 GA patients identified a case with a partial heterozygous deletion of the functional OAT gene located on chromosome 10, no detectable OAT mRNA, and a barely detectable level of OAT antibody-reactive protein. The rest of the cases showed grossly normal OAT gene, mRNA, and variably reduced levels of OAT protein. A restriction fragment length polymorphism (RFLP) was identified in the functional OAT gene sequence with EcoRI which may be useful for prenatal diagnosis of GA. RFLPs were also identified in the OAT-related gene sequences located on the X chromosome with Hind III and Pst I which may potentially show linkage to X-linked retinitis pigmentosa locus. The finding of an OAT gene, mRNA, and protein defect in a GA case constitutes the first real demonstration of the molecular genetic defect of OAT in GA.
This PDF is available to Subscribers Only